OzakiT., UchidaH., IrikuraT.: Studies on metabolism of AM-715 in humans by high-performance liquid chromatography. Chemotherapy, 29; 128 (1981).
2.
ItoA., HiraiK., InoueM., KogaM., SuzueS., IrikuraT., MitsuhashiS.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob. Agents Chemother., 17; 103 (1980).
3.
DownsJ., AndrioleV. T., RyanJ. L.: In vitro activity of MK 0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 21; 670 (1982).
4.
NewsomS. W. B., MatthewsI., AmphlettM., WarrenR. F.: Norfloxacin and the antibacterial pyridone beta-carboxylic, acids. J. Antimicrob. Chemother., 10; 25 (1982).
5.
KhanM. Y., GruningerR. P., NelsonS. M., KlickerR. E.: Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates. Antimicrob. Agents Chemother., 21; 848 (1982).
6.
CorradoM. L., CherubinC. E., ShulmanM.: The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria. J. Antimicrob. Chemother., 11; 369 (1983).
7.
TenneyJ. H., WarrenJ. W.: Bactericidal activity of norfloxacin and nine other urinary tract antibiotics against Gram-negative bacilli causing bacteriuria in chronically catheterized patients. J. Antimicrob. Chemother., 11; 287 (1983)
8.
SiegelS.: Non parametric statistics for the behavioral science, p. 96. McGraw-Hill Ed., 1956.
